DNA damage NF-κB cancer
- User
DNA damage NF-κB cancer
- Assistant
NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a transcription factor complex that plays a pivotal role in regulating immune responses, inflammation, cell proliferation, and survival. Its activation is triggered by various stimuli, including DNA damage.
Activation of NF-κB by DNA Damage:
Upon DNA damage, a specific pathway involving receptor-interacting protein kinase 1 (RIPK1) is activated. In this pathway, RIPK1 mediates the interaction between PIDD (p53-induced protein with a death domain), NEMO (NF-κB essential modulator), and IKK (IκB kinase) subunits. This interaction leads to the activation of the IKK complex following its association with ATM kinase, a protein stimulated by DNA double-strand breaks. The binding between RIPK1 and PIDD through their death domains is believed to promote cell survival by counteracting pro-apoptotic complexes[1].
NF-κB's Role in Cancer:
Aberrant activation of NF-κB is frequently observed in various cancers. This persistent activation can lead to the expression of genes that promote cell proliferation and survival, contributing to tumorigenesis. Consequently, NF-κB has become a significant target for cancer therapy. Inhibiting NF-κB signaling has shown potential in limiting cancer cell proliferation and enhancing the effectiveness of anti-cancer agents[2].
In summary, NF-κB serves as a crucial mediator in the cellular response to DNA damage, influencing cell survival and death. Its dysregulation is closely associated with cancer development, making it a focal point in the search for therapeutic interventions.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.